ESMO Congress 2022 - Biognosys

ESMO Congress 2022

At this year’s ESMO Congress, Biognosys was proud to present 2 poster presentations:

Poster Presentations

Prognostic Impact of MARCO and OAS1 Expression in Metastatic Melanoma Patients Treated With Anti-PD1: a Proteomics and Transcriptomics Retrospective Analysis

Presenter: Domenico Mallardo (Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy)

Poster presented at ESMO 2022

READ MORE

PAK4 as a Potential Marker for Poor Response to Immunotherapy in Melanoma Patients

Presenter: Mitchell P. Levesque (University of Zurich, Switzerland)

Poster presented at ESMO 2022

READ MORE

Do not hesitate to contact our scientific experts at services@biognosys.com to discuss how our proteomics solutions can support your oncology research with transformative insights from discovery to clinic.

Stay Tuned for Future Events

Contact

    By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More